Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Which Crypto Has the Best Chart? Peter Brandt Compares XRP, Monero and Solana

Which Crypto Has the Best Chart? Peter Brandt Compares XRP, Monero and Solana

BeInCryptoBeInCrypto2026/10/06 14:12
Veteran trader Peter Brandt recently published a weekly chart comparison of XRP, Monero, and Solana. He judged each asset purely on classical price patterns and measured moves. His verdict places XRP behind its peers, and the reasons show how chart structure separates strong setups from weak ones. How Brandts Chart Comparison Treats XRP Brandts chart comparison is a price-only technical review of three assets on weekly charts. It sets fundamentals aside and relies on classical patterns and measured moves. His core message is simple: chart structures evolve, targets are not sacred, and relative strength varies widely across assets. For XRP, Brandt identifies a cup-and-handle formation. That pattern is a rounded base followed by a small pullback, and traders often read it as a continuation signal. On a larger timeframe, it may form the right shoulder of a broader inverted head-and-shoulders pattern. A measured move from an inverted head-and-shoulders, based on daily closes, gives an upside objective near $2.16. He qualifies that target right away, because the right shoulder looks poorly formed and abbreviated. XRP Price Performance. XRP also faces heavy overhead supply, which means layers of prior trading that create resistance. Brandt calls this congestion a clear technical negative. Price must absorb it before any sustained advance can begin. Until then, the $2.16 objective stays a conditional target rather than a forecast. Why Does Brandt Prefer Monero and Solana Over XRP? Brandt presents Moneros chart as far more constructive. XMR has largely absorbed its previous overhead supply. He describes the path ahead as clear sailing. The weekly structure shows progressively higher highs and a cleaner path after earlier consolidations. He names it his clear favorite among the group. He says he does not need any fundamental narrative attached to XMR. Monero (XMR) Price Performance. Solana earns similarly favorable treatment. Brandt highlights a cup-and-handle pattern on a larger, more impressive scale than XRPs. SOLs weekly chart shows a broad rounded base under a well-defined horizontal resistance line. That setup suggests a higher-quality continuation once the level resolves. Some congestion remains, but the structure looks cleaner and more decisive. Solana (SOL) Price Performance. Brandt also briefly compares Ethereum and Stellar. ETH carries heavy congestion without XRP-type overhead supply, while XLM faces less resistance. Throughout the post, he stresses a pure price-action approach: he trades charts, not stories. He asks XRP holders not to take the weaker chart personally, since patterns morph and measured moves can fail.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals

October 9 – Goldman Sachs pointed out that India's implementation of a 30% profit margin cap on non-scheduled anticancer drugs (link) will have limited impact on hospitals. The report states that, based on preliminary discussions with hospital chain groups, such drugs account for less than 5% of hospital revenue and 2% to 2.5% of operating profit. The report adds that hospitals can offset the losses by slightly adjusting service charges, such as administration fees. According to a government notice, an expert committee will finalize the list of drugs to be brought under regulation. Driven by the anticipated price cap, the share prices of Max Healthcare MAXE.NS, Apollo Hospitals APLH.NS, and Fortis Healthcare FOHE.NS rose by 1.6% to 2.5%. Previously, since September 30, these stocks had collectively declined by 11% to 11.5%. Year-to-date, FOHE and MAXE are down 11.7% and 14.8%, respectively, while APLH has risen by 11%. (To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. Due to potential errors or missing context in automated translations, Reuters does not guarantee the accuracy of automatic translation texts and offers them solely for readers’ convenience. Reuters accepts no responsibility for any damage or loss caused by using these automated translation features.)

路透社•2026/10/09 04:26
BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals

Adding insult to injury! Japanese electronics giant Nidec downgraded by UBS, stock price plunges over 9% and approaches an 11-month low

UBS has downgraded Nidec's rating from "Buy" to "Neutral" and lowered its target price from 2,800 yen to 2,400 yen, citing a more challenging market environment.

智通财经•2026/10/09 03:53